Both stocks have been underperformers.
The stock of the health plan provider has not been able to show any sustained strength.
Bristol-Myers offers a terrific combination of yield, dividend safety, and dividend growth for income-focused investors.
Here are our price objectives.
Let's take a look at 2 charts.
We're now expecting further strength.
Large purchases of Cortexyme Inc. and NantHealth Inc. shares have been made by insiders recently.
Here's where traders should look to buy a pullback.
Traders could go long CI at current levels, and we have two price objectives.
Let's look at this impossible move on the market -- and why health care could be coming off life support.